NuVasive

NuVasive

Medical device company developing minimally disruptive surgical products and procedurally integrated solutions for the spine. Learn more

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD201720182019202020212022
Revenues1.0b1.1b1.2b1.1b1.1b1.2b
% growth-7 %6 %(10 %)8 %6 %
EBITDA232m176m253m176m181m212m
% EBITDA margin23 %16 %22 %17 %16 %18 %
Profit81.6m12.5m65.2m(37.2m)(64.1m)40.4m
% profit margin8 %1 %6 %(4 %)(6 %)3 %
R&D budget50.4m61.7m72.4m79.8m92.6m98.5m
R&D % of revenue5 %6 %6 %8 %8 %8 %

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$15.0m

Early VC

$9.8m

Early VC
N/A

N/A

IPO
N/A

$40.5m

Post IPO Equity
*

N/A

Acquisition
Total Funding€22.5m

Recent News about NuVasive

Edit
More about NuVasiveinfo icon
Edit

NuVasive is a leading medical technology company specializing in minimally invasive spine surgery solutions. Operating in the healthcare market, NuVasive serves hospitals, surgeons, and healthcare providers by offering a comprehensive portfolio of products and services designed to improve patient outcomes and streamline surgical procedures. The company's core business model revolves around the development and commercialization of advanced surgical tools, implants, and integrated procedural solutions that facilitate less invasive spine surgeries. NuVasive generates revenue through the sale of its proprietary surgical systems, implants, and related services, as well as through ongoing support and training for healthcare professionals. By focusing on innovation and procedural efficiency, NuVasive aims to reduce surgical times, minimize patient recovery periods, and enhance overall clinical results. Key markets include North America, Europe, and Asia-Pacific, with a strong emphasis on expanding its global footprint.

Keywords: minimally invasive, spine surgery, surgical tools, implants, procedural integration, healthcare, innovation, patient outcomes, global market, medical technology.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by NuVasive

Edit
Ellipse Technologies
ACQUISITION by NuVasive Jan 2016
SafePassage
ACQUISITION by NuVasive Dec 2017
Biotronic NeuroNetwork
ACQUISITION by NuVasive Jun 2016